期刊文献+

辛伐他汀未能改善5/6肾切除大鼠自体动静脉内瘘血管内膜增生 被引量:1

Simvastatin Therapy is not Associated with Improved Autogenous Internal Arteriovenous Fistula in Neointimal Hyperplasis on 5/6 Nephrectomy Rats Outcomes
下载PDF
导出
摘要 目的:观察辛伐他汀对5/6肾切除大鼠自体移植静脉内膜增生的影响,探讨其防治透析内瘘内膜增生是否有潜在的价值。方法:36只大鼠随机分为3组:假手术组、CRF对照组和CRF他汀组各12只。各组在成模后分别于第7天、28天各处死6只,抽血行肾功能、血脂检测,并取其内瘘内膜组织行组织病理学检查。比较相同时间点各组肾功能,血脂及内膜增生程度。结果:(1)肾功能和血脂:与同一时点假手术组相比,CRF对照组、CRF他汀组造模后第7、28天后的肌酐和尿素氮均显著增高(P<0.05),各组血脂无显著差异。(2)新生内膜面积、厚度测定:术后第7天,已见各组内瘘血管内膜受损、薄层新生内膜形成;第28天病理改变更明显。与假手术组相比,CRF对照组、CRF他汀组两组内膜增生更为明显(P<0.05);CRF对照和CRF他汀两组之间比较差异无统计学意义(P>0.05)。(3)免疫组化α-SMA、PCNA:假手术组与CRF对照组、假手术组与CRF他汀组比较差异均有统计学意义(P<0.05);CRF对照组与CRF他汀组之间差异无统计学意义(P>0.05)。结论:辛伐他汀未能改善慢性肾功能不全自体动静脉内瘘大鼠的血管内膜增生。 Objective:To investigate the effectness of simvastatin on neointimal hyperplasis of autogenous internal arteriove- nous fistula in rats model with chronic renal failure by 5/6 nephreetomy. Methods:36 rats were randomly divided into three groups: sham group, CRF control group and CRF statin group of 12 each . CRF models were made by 5/6 nephrectomy and then followed by end - to - end anastomosis of the right carotid artery and internal jugular vein. After the operation for 7 and 28 days, rats were sacri- riced, and the blood sample was taken for renal funtion and lipids, also the vein near the anastomosis site were examined for histologi- cal changes after staining with HE, combined staining for elastic and collagen rihem, and immunohistochemieal staining for alpha SMA and PCNA. Results: ( 1 ) Renal function and ]ipids : Blood creatinine and BUN levels were significantly increased in the CRF control group and CRF statin group than sham group( P 〈 0.05 ) , but the level of blood lipids was similar in all three groups. (2)the degree of neointimal hyperplasia: The results showed that vein tissue near anastomotic stoma occured generous VSMC and collagen fiber pro- liferation ,neointimal hyperplasia after operation, the CRF control and CRF statin groups were significantly increased compared to sham group ( P 〈 0.05 ), the results were similar for CRF group versus CRF statin group ( P 〉 0.05 ). ( 3 ) Immunohistochemisty re- suits showed that alpha SMA, PCNA were significantly increased in CRF control and CRF statin groups compared to sham group (P 〈 0.05 ), but bad no statistically significant between CRF control group and CRF statin group ( P 〉 0.05 ). Conclusion: Simvastatin therapy is not associated with improved autogenous internal arteriovenous fistula in neointimal hyperplasis on 5/6 Nephrectomy rats outcomes.
出处 《中国中西医结合肾病杂志》 2013年第1期26-28,I0005-I0006,共5页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 温州市科技局基金资助项目(No.Y20090205)
关键词 辛伐他汀 自体移植静脉 内膜增殖 5 6肾切除 Simvastatin Arteriovenous fistula Neointima hyperplasia 5/6 nephrectomy
  • 相关文献

参考文献8

  • 1Kokubo T,Ishikawa N,Uchida H,et al. CKD Accelerates Devel- opment of NeointimalHyperplasia in Arteriovenous Fistulas. J Am Soc Nephrol,2009,20 (6) : 1236 - 1245.
  • 2宋自芳,李伟,郑启昌,尚丹,熊俊,管思明.阿托伐他汀对大鼠自体移植静脉内膜增生的影响[J].中国病理生理杂志,2009,25(4):631-635. 被引量:3
  • 3Corpataux JM, Naik J, Porter KE, et al. The effectof six different statins on the proliferation, migration, and invasion of human smooth muscle cells. J Surg Res,2005,129 (1) : 52 -56.
  • 4徐海山,庄永泽.他汀类药物对肾脏非降脂保护作用[J].中国中西医结合肾病杂志,2007,8(3):185-186. 被引量:2
  • 5Saran R, Dykstra DM, Wolfe RA, et al. Association between vas- cular access failure and the use of specific drags: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis,2002,40 : 1255 - 1263.
  • 6Szmitko PE, Fedak PW, Weisel RD, et al. Endothelial progenitor ceils: New hope for abmken heart. Circulation,2003,107 (24) : 3093 -3100.
  • 7Pisoni R, Barker- Finkel J, Allon M, et al. Statin Therapy Is Not Associated with Improved Vascular Access Outcomes. Clin J Am Soc Nephrol,2010,5(8) :1447 - 1450.
  • 8Roy - Chaudhury P, Sukhatme VP, Cheung AK, et al. Hemodialy- sis vascular access dysfunction: A cellular and molecular view- point J. Am Soc Nephml,2006,17(4) :1112 - 1127.

二级参考文献35

  • 1Conte MS,Bandyk DF,Clowes AW,et al.Results of PREVENT III:a multicenter,randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery[J].J Vasc Surg,2006,43(4):742-751.
  • 2Zhang L,Hagen PO,Kisslo J,et al.Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model[J].J Vasc Surg,2002,36(4):824-832.
  • 3Turner NA,Ho S,Warburton P,et al.Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation,invasion,and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells[J].J Vasc Surg,2007,45(5):1022-1028.
  • 4Fogelstrand P,Osterberg K,Mattsson E.Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue[J].Cardiovasc Res,2005,67(2):326-332.
  • 5Poli A.Atorvastatin:pharmacological characteristics and lipid-lowering effects[J].Drugs,2007,67(Suppl 1):3-15.
  • 6Sever PS,Dahlf B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial[J].Lancet,2003,361(9364):1149-1158.
  • 7Corpataux JM,Naik J,Porter KE,et al.The effect of six different statins on the proliferation,migration,and invasion of human smooth muscle cells[J].J Surg Res,2005,129(1):52-56.
  • 8Monahan TS,Andersen ND,Panossian H,et al.A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells:modulation of cell migration and proliferation[J].J Vasc Surg,2007,45(3):581-589.
  • 9Wang CY,Liu PY,Liao JK.Pleiotropic effects of statin therapy:molecular mechanisms and clinical results[J].Trends Mol Med,2008,14(1):37-44.
  • 10Rubba P.Effects of atorvastatin on the different phases of atherogenesis[J].Drugs,2007,67(Suppl 1):17-27.

共引文献3

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部